Wilfred Angie Abia | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Wilfred Angie Abia | Developmental Neuroscience | Best Researcher Award

Dr. Wilfred Angie Abia |  University of Yaounde 1 | Cameroon

Wilfred Angie Abia is an accomplished biochemist and food safety toxicologist whose career bridges Africa and Europe through impactful teaching, research, and international collaborations. His academic foundation in medical biochemistry, nutrition, and toxicology has evolved into a distinguished career specializing in food contaminants, mycotoxin biomonitoring, fraud detection, and risk assessment. He has held influential postdoctoral and leadership positions in projects addressing agri-food safety and consumer health protection. His contributions span mycotoxicology, food fraud prevention, One Health research, and climate-related food safety challenges. Beyond research, he plays an important role as a senior lecturer and mentor, advancing both academic excellence and professional training in food safety.

Profile

Google Scholar
Orcid
Scopus

Early Academic Pursuits

Wilfred Angie Abia began his academic journey with a strong foundation in biochemistry, focusing on medical laboratory technology, nutritional sciences, and food safety. His doctoral studies at the University of Yaoundé I provided him with advanced expertise in food contaminants, safety, and biomonitoring of multimycotoxin exposures. His early academic years were marked by interdisciplinary training that connected biochemistry, nutrition, toxicology, and public health, setting the stage for his specialized career in agri-food safety and toxicology.

Professional Endeavors

His professional career spans teaching, research, and project management across multiple institutions and international collaborations. He has held postdoctoral fellowships and senior research positions in Africa, Europe, and the United Kingdom, where he advanced projects on food safety, toxicology, and fraud detection. His work at Queen’s University Belfast included leadership roles in large-scale European initiatives, where he served as both a researcher and project manager. As a Senior Lecturer of Biochemistry and Food Safety/Toxicology at the University of Yaoundé I, he combines teaching, mentorship, and research with program coordination responsibilities, shaping the next generation of food safety professionals.

Contributions and Research Focus

Abia’s research focuses on food contaminants, safety, and human health with a special emphasis on mycotoxicology. He has pioneered studies in exposure assessment, biomarker development, and human biomonitoring, particularly in vulnerable populations. His work extends to food integrity, authenticity, fraud detection, and traceability, ensuring consumer health protection. He has contributed significantly to toxicological risk assessments of chemicals in food, drugs, and the environment, while also addressing broader themes such as climate change, food security, and the One Health approach. His unique contributions include research into the neurotoxicology of mycotoxins, highlighting the intersection of food safety and neuroscience.

Accolades and Recognition

Throughout his career, Abia has been recognized through prestigious international research fellowships and visiting scholar positions in leading research centers across Europe and Africa. His involvement in high-impact projects such as MycoMarker and FoodSafer underscores his leadership in global food safety initiatives. His achievements are further strengthened by professional certifications, including specialized training in food fraud prevention, which demonstrate his commitment to continuous professional growth and excellence in his field.

Impact and Influence

His work has had a profound impact on advancing food safety research, shaping policies, and protecting public health. By bridging biochemistry with toxicology, agri-food safety, and environmental sciences, he has influenced how food contaminants and fraud are detected and managed. His role as a lecturer and mentor ensures that his expertise is transmitted to students and young researchers who will continue to advance the field. His contributions also extend to policy and science diplomacy, where he actively promotes interdisciplinary collaboration for sustainable solutions in food and health security.

Legacy and Future Contributions

Abia’s legacy lies in his dedication to safeguarding food systems, advancing toxicological research, and promoting interdisciplinary approaches that connect human, animal, and environmental health. His work in mycotoxin biomonitoring and neurotoxicology offers critical insights into the hidden health risks of food contamination. Looking ahead, his future contributions are likely to expand in areas of food fraud prevention, climate-smart agriculture, and One Health frameworks, ensuring resilient food systems for global populations. His combination of research excellence, teaching, and science diplomacy positions him as a thought leader in shaping the future of food safety and toxicology.

Publications

  • Title: Determination of multi-mycotoxin occurrence in cereals, nuts and their products in Cameroon by liquid chromatography tandem mass spectrometry (LC-MS/MS)
    Authors: WA Abia, B Warth, M Sulyok, R Krska, AN Tchana, PB Njobeh, MF Dutton, …
    Year: 2013

  • Title: Mycotoxin exposure in rural residents in northern Nigeria: A pilot study using multi-urinary biomarkers
    Authors: CN Ezekiel, B Warth, IM Ogara, WA Abia, VC Ezekiel, J Atehnkeng, …
    Year: 2014

  • Title: Development and validation of a rapid multi‐biomarker liquid chromatography/tandem mass spectrometry method to assess human exposure to mycotoxins
    Authors: B Warth, M Sulyok, P Fruhmann, H Mikula, F Berthiller, R Schuhmacher, …
    Year: 2012

  • Title: Bio-monitoring of mycotoxin exposure in Cameroon using a urinary multi-biomarker approach
    Authors: WA Abia, B Warth, M Sulyok, R Krska, A Tchana, PB Njobeh, PC Turner, …
    Year: 2013

  • Title: Ultra-sensitive, stable isotope assisted quantification of multiple urinary mycotoxin exposure biomarkers
    Authors: B Šarkanj, CN Ezekiel, PC Turner, WA Abia, M Rychlik, R Krska, M Sulyok, …
    Year: 2018

  • Title: Low doses of mycotoxin mixtures below EU regulatory limits can negatively affect the performance of broiler chickens: A longitudinal study
    Authors: O Kolawole, A Graham, C Donaldson, B Owens, WA Abia, J Meneely, …
    Year: 2020

  • Title: Urinary analysis reveals high deoxynivalenol exposure in pregnant women from Croatia
    Authors: B Šarkanj, B Warth, S Uhlig, WA Abia, M Sulyok, T Klapec, R Krska, …
    Year: 2013

Conclusion

Wilfred Angie Abia’s work exemplifies a rare integration of scientific expertise, international leadership, and educational impact. His contributions to food safety, toxicology, and agri-food research not only safeguard public health but also strengthen global food systems. With his continued focus on innovation, interdisciplinary approaches, and capacity building, he stands as a key figure in shaping the future of food safety science and policy worldwide.

Rania Awadi | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Rania Awadi | Developmental Neuroscience | Best Researcher Award

Dr. Rania Awadi |  Higher Institute of Medical Technologies of Tunis | Tunisia

Dr. Rania Awadi is a biophysics and medical imaging researcher whose work centers on cardiac biomechanics and non-invasive diagnostic techniques. With a PhD in biophysics and medical imaging, she has conducted advanced studies on left ventricle biomechanics using finite element modelling and gained international experience through research internships in France and collaborations with leading medical institutions in Tunisia. Her research expertise lies in cardiovascular MRI, image processing, and myocardial strain assessment, particularly in pediatric populations where diagnostic challenges are more pronounced. Among her significant contributions is a study on Duchenne Muscular Dystrophy, where she applied cardiac MRI feature tracking to identify early subclinical myocardial dysfunction without contrast agents, an advancement with meaningful clinical impact.

Profile

Google Scholar

Early Academic Pursuits

From the outset of her academic journey, Dr. Rania Awadi cultivated a strong foundation in biophysics, medical physics, and medical imaging. Her doctoral studies at the Higher Institute of Medical Technologies of Tunis were marked by a deep focus on the biomechanics of the left ventricle, where she applied finite element modelling to explore complex cardiac dynamics. Early research internships at prestigious institutions such as IMT Atlantique in France and Sorbonne University enriched her academic profile, enabling her to refine her expertise in advanced imaging and computational modelling techniques.

Professional Endeavors

Building upon her academic training, Dr. Awadi advanced into professional roles that merged teaching and research. She joined the Higher Institute of Medical Technologies of Tunis as a lecturer in biomechanics, where she has contributed to shaping future professionals in medical physics and imaging. Her work also extended to clinical collaborations, including her involvement with the Principal Military Hospital of Tunis and Monji Ben Hmida Center, emphasizing translational research that bridges scientific innovation with patient care.

Contributions and Research Focus

Dr. Awadi’s contributions to medical science are anchored in cardiovascular imaging and cardiac biomechanics. Her expertise lies in cardiac magnetic resonance imaging, image processing, and computational modelling, with a particular focus on assessing myocardial strain. She has addressed the unique challenges of pediatric populations, where smaller heart sizes, higher heart rates, and variability in strain demand precise methodologies. Her research has sought to make early diagnosis more accessible and reliable, especially in vulnerable groups affected by genetic and muscular disorders.

Pioneering Research on Duchenne Muscular Dystrophy

Among her notable achievements, Dr. Awadi conducted a pioneering study on myocardial strain assessment for early diagnosis of Duchenne Muscular Dystrophy in pediatric patients using cardiac MRI. Through the application of feature tracking techniques, she demonstrated the feasibility of detecting subclinical myocardial dysfunction without the use of contrast agents, reducing risks in younger patients. Her findings, published in Applied Sciences, underscored significant associations between myocardial strain parameters and structural cardiac changes, providing a non-invasive tool for monitoring disease progression in affected children.

Accolades and Recognition

Dr. Awadi’s scholarly contributions have been recognized in the international research community through publication in high-impact journals. Her work in Applied Sciences has strengthened her standing as an emerging researcher in cardiac imaging and biomechanics. Her collaborations with European and Tunisian research institutions reflect her growing reputation as a scientist capable of fostering cross-border innovation in medical imaging and biomechanics.

Impact and Influence

The impact of Dr. Awadi’s research extends beyond academic recognition to meaningful influence on clinical practices. By offering new insights into myocardial strain assessment, she has contributed to refining diagnostic approaches for conditions like Duchenne Muscular Dystrophy, where early intervention can significantly alter outcomes. Her teaching and mentorship also shape a new generation of researchers and clinicians, further amplifying the reach of her work across academia and healthcare.

Legacy and Future Contributions

Looking ahead, Dr. Awadi’s career continues to chart a path of scientific advancement and clinical relevance. With expertise spanning biomechanics, MRI, and computational modelling, she is poised to deepen investigations into cardiac function across diverse patient populations. Her future contributions are expected to expand the frontiers of non-invasive diagnostics, ensuring that her legacy in cardiovascular biomechanics and imaging is defined by both innovation and tangible impact on patient health.

Publications

Numerical study of two microwave antennas dedicated to superficial cancer hyperthermia
N. Benameur, R. Awadi, A. Bouabidi, M.A. Mohammed, M.U. Rehman, … – 2024

A quasi-static biomechanical model of the human myocardium based on Cardiac Magnetic Resonance images
R. Awadi, N. Benameur, T. Kraiem, L. Salam – 2023

Comparison of Left Ventricle Deformation Analysis Using Abaqus and CVi42 Software: Insights from Healthy Subjects and patients with Myocardial Infarction
R. Awadi, N. Benameur, A. Sleimi, L. Salam – 2025

Myocardial Strain Assessment for Early Duchenne Muscular Dystrophy Diagnosis in Pediatric Patients Using Cardiac MRI
R. Awadi, N. Benameur, H. Hafsi, T.B. Younes, Y. Arous, S. Labidi, … – 2024

Left Ventricle Wall Motion Abnormalities Detection in Cardiac MRI
N. Benameur, R. Awadi, R. Mahmoudi, M. Deriche, M. Al Betar – 2023

Finite Element of Biomechanical Model of the Human Myocardium from a Cardiac MRI Images
A. Rania, N. Benameur, T. Kraiem, S. Labidi – 2022

of the Human Myocardium from a Cardiac MRI Images
A. Rania, N. Benameur, T. Kraiem, S. Labidi – 2022

Conclusion

Dr. Awadi’s career reflects a blend of academic rigor, professional dedication, and innovative research that addresses pressing clinical needs in pediatric cardiology. Her work has advanced the understanding of myocardial strain assessment, offering tools that improve early diagnosis and patient care. Through her teaching, collaborations, and published research, she has established herself as a promising figure in cardiac imaging and biomechanics. Looking forward, her contributions are set to further bridge the gap between research and clinical application, reinforcing her role as a driving force in the development of non-invasive diagnostic technologies.

Kumud Bala | Molecular and Cellular Neuroscience | Excellence in Research Award

Published on by Neuroscientists

Prof. Kumud Bala | Molecular and Cellular Neuroscience | Excellence in Research Award

Prof. Kumud Bala, Amity University, India.

Prof. Kumud Bala is a seasoned academic and researcher in the fields of biotechnology and immunology, with a rich educational background that includes a Ph.D. from Patna University in collaboration with AIIMS. She has over 25 years of teaching and research experience, primarily at Amity University, Noida, where she currently holds the position of Professor at the Amity Institute of Biotechnology. Her professional journey has been marked by consistent progression, interdisciplinary teaching, and impactful research. She has contributed significantly to biotechnology education through curriculum development, student mentorship, and translational research projects that align closely with real-world biomedical challenges.

Profile

Google Scholar
Orcid
Scopus

Early Academic Pursuits

Prof. Kumud Bala’s academic journey began with a strong foundation in the life sciences at Patna University, where she earned her B.Sc. in Zoology in 1992, followed by an M.Sc. in Immunology in 1995. Her passion for understanding the intricate mechanisms of biological systems led her to pursue a Ph.D. in Biotechnology, a collaborative program between Patna University and AIIMS, which she successfully completed in 2003. This solid educational background laid the groundwork for her long-standing academic and research career in the field of biotechnology and immunology.

Professional Endeavors in Higher Education

Prof. Bala has cultivated a distinguished teaching and research career over nearly three decades, beginning in 1996 as a Lecturer at St. Columba’s College, Hazaribag, where she contributed for over a decade. She later joined Amity University, Noida, where she steadily rose through the academic ranks—from Senior Lecturer at the Amity Institute of Advanced Training and Research to Expert Faculty at the Amity Institute of Pharmacy, and eventually to Assistant Professor III in 2009. Her dedication and academic excellence led to her promotion as Associate Professor in 2013, and she currently serves as a Professor at the Amity Institute of Biotechnology since 2019. Her professional journey is a testament to her unwavering commitment to knowledge dissemination and academic leadership.

Contributions and Research Focus

Prof. Bala’s research primarily revolves around biotechnology and immunology, with deep insights into molecular mechanisms of disease, therapeutic interventions, and diagnostic innovations. Her work often bridges interdisciplinary domains, particularly in translational research aimed at addressing immunological disorders and enhancing biotechnological applications in healthcare. Through her roles in academia, she has significantly contributed to shaping curricula, mentoring research scholars, and advancing scientific inquiry in life sciences. Her scholarly output reflects a commitment to both foundational and applied research in biomedical biotechnology.

Accolades and Recognition

While explicit accolades are not detailed in the record, Prof. Bala’s rise through academic ranks and continued tenure at a leading private university in India—Amity University—indicates a high level of institutional recognition. Her roles have involved strategic responsibilities in curriculum development, research coordination, and interdisciplinary teaching, underscoring her reputation as a trusted educator and researcher. The trust placed in her for long-term roles across diverse faculties also reflects professional respect and recognition among peers.

Impact and Influence on Biotechnology Education

Prof. Bala has profoundly influenced biotechnology education in India through her dynamic teaching methodologies and innovative research projects. Her involvement in training students from pharmacy, advanced research, and biotechnology backgrounds positions her at the center of a multidisciplinary educational landscape. Her ability to integrate academic theory with practical applications has shaped the perspectives of numerous undergraduates, postgraduates, and research aspirants, many of whom have pursued impactful careers in biomedical sciences and allied fields.

Legacy in Research and Mentorship

A hallmark of Prof. Bala’s career is her enduring legacy as a mentor and scientific guide. Her role in mentoring early-career scientists and guiding them through complex research problems stands as one of her most valuable contributions to academia. Her collaborative ethos, combined with her scientific rigor, has fostered a culture of excellence and innovation. Her efforts have ensured that research in biotechnology not only thrives in academic settings but also responds to real-world health challenges.

Future Vision and Continuing Contributions

Looking ahead, Prof. Kumud Bala continues to be an influential voice in biotechnology and immunology, actively participating in the academic and scientific community at Amity University and beyond. With the growing importance of biotechnology in global healthcare, she is uniquely positioned to lead future projects focused on interdisciplinary research, biomedical innovation, and policy-oriented science education. Her unwavering commitment to scientific growth and mentorship guarantees that her impact will be felt for generations to come.

Publication

1. Morphological examination of ear: a study of an Indian population – PK Chattopadhyay, S Bhatia – 2009


2. Herbal contraceptive: an overview – K Bala, M Arya, DP Katare – 2014


3. Adverse effect of combined oral contraceptive pills – A Shukla, R Jamwal, K Bala – 2017


4. Dealing Wildlife Offences in India: Role of the Hair as Physical Evidence – VT V Sahajpal, SP Goyal, Kumudbala Singh – 2009


5. In vitro antioxidant activity of defatted seed extracts of Ocimum sanctum on rat PC-12 cells and its inhibitory efficacy with receptors of oral squamous cell carcinoma – Y Sharma, M Bharadwaj, N Srivastava, A Kaur, M Kumar, M Agarwal, … – 2020


6. In-vitro antiproliferative efficacy of Abrus precatorius seed extracts on cervical carcinoma – A Kaur, Y Sharma, A Kumar, MP Ghosh, K Bala – 2022


7. Antioxidant activity of polyphenolic flavonoid of stem of Nicotiana tabacum – Y Sharma, A Nagar, NS Srivastava, K Bala – 2017


8. Comparative study of different parts of fruits of Musa Sp. on the basis of their antioxidant activity – Y Sharma, A Chauhan, K Bala, A Nagar – 2016


9. Preclinical assessment of stem of Nicotiana tabacum on excision wound model – Y Sharma, A Kaur, R Bhardwaj, N Srivastava, M Lal, S Madan, K Bala – 2021


10. Nosocomial infection by non-fermenting gram negative bacilli in tertiary care hospital: Screening and cure – R Wadhwa, Y Sharma, RP Upadhyay, K Bala – 2016

 

Conclusion

Prof. Kumud Bala’s career reflects a strong blend of academic rigor, research excellence, and educational leadership. Through her deep involvement in immunology and biotechnology, she has shaped the academic paths of numerous students and contributed to advancing science education in India. Her enduring commitment to scientific inquiry, mentorship, and innovation positions her as a respected figure in her field. Moving forward, her work promises to continue influencing both academic advancement and practical healthcare solutions, reinforcing her role as a pivotal contributor to the growth of life sciences in higher education.

 

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr.  Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

 

  • Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

 

  • Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

 

  • Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

 

  • Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

 

  • Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

 

  • Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

 

  • A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

 

  • Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

 

  • Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

 

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.

Daon Hwang | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Daon Hwang | Clinical Neuroscience | Best Researcher Award

Mr. Daon Hwang,  Depatment of Physical Therapy, Korea Natiional University of Transportation,  South Korea.

Daon Hwang is a dedicated physical therapist and Ph.D. candidate at Korea National University of Transportation, with a strong academic and clinical foundation in adult neurological rehabilitation. His research portfolio includes six completed projects and six peer-reviewed publications, focusing on stroke rehabilitation, gait analysis, neurorehabilitation, and assistive device development. With a practical background in clinical therapy and consulting experience in device usability, he effectively bridges the gap between research and real-world application. His active involvement in professional organizations further enriches his contributions to the rehabilitation field.

Profile

Orcid

🎓 Early Academic Pursuits

Daon Hwang began his academic journey with a deep interest in the human body and its recovery mechanisms, leading him to pursue a career in physical therapy. He earned both his Bachelor’s and Master’s degrees in Physical Therapy from Korea National University of Transportation (KNUT). His early academic years were marked by diligence and a curiosity-driven approach to the complexities of neurological rehabilitation. His strong academic performance and growing passion for evidence-based practice set the stage for his current doctoral research.

💼 Professional Endeavors

As a licensed physical therapist, Daon Hwang has accumulated meaningful clinical experience, particularly in the field of adult neurological rehabilitation. His hands-on work with stroke patients has fueled his commitment to integrating practical therapy with innovative research. His current role as a Ph.D. candidate at KNUT allows him to bridge clinical practice with academic exploration, where he also provides consultancy on assistive devices. Daon continues to evolve both as a practitioner and as a scholar in the rehabilitation sciences.

🧠 Contributions and Research Focus

Daon’s primary research focuses include stroke rehabilitation, neurorehabilitation, gait analysis, and the development of assistive technologies. He has successfully completed six research projects, exploring diverse aspects such as proprioceptive training and the usability of rehabilitation devices. His scholarly output includes six peer-reviewed journal publications—two in SCI-indexed journals and four in KCI-indexed journals. These works contribute to enhancing therapeutic protocols and improving patients’ functional outcomes, particularly in post-stroke recovery.

🧪 Research Innovation and Impact

Daon’s innovative contributions are evident in his work with assistive device usability, having collaborated on three industry consulting projects to improve device design and user experience for stroke patients. His research has not only advanced academic knowledge but also offered real-world applicability in clinical settings. His studies often highlight the integration of biomechanical analysis and rehabilitation techniques to create more personalized and effective interventions.

🏅 Accolades and Professional Involvement

While Daon Hwang has not yet published books or acquired patents, his membership in several esteemed professional bodies reflects his dedication to continued learning and contribution to the field. He is an active member of the Korean Academy of Orthopedic Manipulative Physical Therapy, the Korean Physical Therapy Association, and the Korea Proprioceptive Neuromuscular Facilitation Association. Through these affiliations, he stays at the forefront of developments in physical therapy and rehabilitation science.

🌍 Influence and Collaboration

Though he has not formally reported collaborative research projects, Daon’s consulting work and clinical partnerships demonstrate a growing sphere of influence. His findings are increasingly referenced by peers and practitioners, particularly in the areas of gait mechanics and neuro-motor rehabilitation. His dual role in academia and practice ensures his research remains grounded in clinical relevance.

🔮 Legacy and Future Contributions

Looking ahead, Daon Hwang aspires to further integrate technology with neurorehabilitation strategies, aiming to develop more efficient, adaptive tools for stroke survivors. His doctoral work and future post-doctoral goals center on refining rehabilitative methods through data-driven research and interdisciplinary collaboration. With a vision of contributing meaningfully to global rehabilitation science, Daon is poised to leave a lasting legacy of innovation, empathy, and excellence in physical therapy.

Publication

  • Title: Usability Test for an Over-Ground Walking Assistance Robotic Device Based on the Mecanum Wheel
    Authors: Daon Hwang; EunPyeong Choi; Ki Hun Cho
    Year: 2025

 

  • Title: Changes in Balance Ability, Physical Performance and Lower Extremity Proprioception according to the Compression Stockings in University Students
    Authors: Daon Hwang; Hyeong Gyu Kim; Na Young Kang; Eun Seo Park; Hyun Young Yoo; Jun Young Lee; Seo Yeong Jang; Cheol Woo Hwang; Ki Hun Cho
    Year: 2025

 

  • Title: Usability Test for a Cane-Combined Weight Support Feedback Device
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2024

 

  • Title: Usability Test for Motion Tracking Gait Assistive Walker
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2023

 

  • Title: The Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke: A Pilot Study
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

  • Title: Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

✅ Conclusion

Driven by a passion for enhancing recovery outcomes in stroke patients, Daon Hwang has positioned himself as a promising scholar and practitioner in the field of physical therapy. His blend of academic rigor, clinical expertise, and innovation in assistive technologies reflects a career marked by meaningful impact and ongoing growth. As he advances toward completing his Ph.D., his work continues to shape the future of neurorehabilitation—promoting evidence-based practices and contributing to patient-centered healthcare innovations.

Elissavet Kollia | Developmental Neuroscience |Best Researcher Award

Published on by Neuroscientists

Ms. Elissavet Kollia | Developmental Neuroscience |Best Researcher Award 

Ms. Elissavet Kollia, National Kapodistrian University of Athens, Greece.

Ms. Elissavet Kollia is a distinguished pediatrician and researcher specializing in pediatric neurology. With an exceptional academic background, she graduated from the Medical School of the Democritus University of Thrace and pursued advanced postgraduate studies in Clinical Pediatrics and Nursing-Research. Her extensive clinical training, from pediatrics specialization to her current role at Konstantopouleio General Hospital “Agia Olga,” has solidified her expertise in child healthcare. Additionally, her research focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, contributing valuable insights to the field. Her dedication extends beyond clinical practice, as seen in her voluntary medical work and commitment to mentoring young professionals.

Profile

Google Scholar

🎓 Early Academic Pursuits

From an early age, Elissavet Kollia demonstrated exceptional academic abilities, graduating from the 4th General Lyceum of Agia Paraskevi with an outstanding general grade of “excellent 19.2.” Her passion for medicine led her to the Medical School of the Democritus University of Thrace, where she was admitted in September 2007. With dedication and perseverance, she successfully earned her medical degree in July 2013, achieving a commendable grade of “very good 8.33.” Shortly after, she obtained her license to practice as a doctor in Greece and later in Munich, Germany, reflecting her international medical competence.

🏥 Professional Endeavors

Ms. Kollia’s professional journey has been marked by extensive clinical training and hands-on experience in pediatrics. She began her specialization at the Pediatric Clinic of the General Hospital of Karpenisi from June 2014 to October 2016. Her commitment to healthcare extended beyond hospitals as she served as a rural doctor at the Primary Health Care Center of Agios Nikolaos, Evrytania, actively participating in emergency care at the General Hospital of Karpenisi. Her expertise deepened when she became a scientific associate at the Pediatric Neurology Unit of the First Pediatric Clinic of the National University of Athens. She then pursued her residency in pediatrics at the First University Pediatric Clinic – Children’s Hospital “Agia Sophia” from November 2018 to May 2022, ultimately obtaining her specialty title in June 2022. Currently, she is serving as a pediatrician at the Konstantopouleio General Hospital “Agia Olga,” continuing her mission to provide excellent pediatric care.

📝 Contributions and Research Focus

Ms. Kollia’s dedication to medical research has significantly contributed to the field of pediatric neurology. Her postgraduate studies in “Clinical Pediatrics and Nursing-Research,” completed with an exceptional grade of “Excellent 9.31,” strengthened her academic foundation. Her ongoing doctoral dissertation at the National Kapodistrian University of Athens focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, a field crucial for advancing neurological care in children. Her research efforts have led to an upcoming publication in the European Journal of Paediatric Neurology, further establishing her as a valuable contributor to the scientific community.

🌟 Accolades and Recognition

Ms. Kollia’s unwavering commitment to medicine has been recognized through her outstanding academic achievements and professional milestones. From excelling in her graduate and postgraduate studies to securing prestigious residency and specialization opportunities, she has consistently demonstrated excellence in her field. Her acceptance into renowned institutions and her involvement in vital research projects underline her credibility and expertise in pediatric neurology.

💪 Impact and Influence

Beyond her clinical and academic contributions, Dr. Kollia has actively participated in voluntary medical programs, extending her expertise to underserved populations. She contributed to emergency case observations at the Children’s Hospital “Agia Sophia” and participated in medical landing programs in remote islands, showcasing her dedication to public health. Her influence extends to mentoring young medical professionals, sharing her knowledge, and contributing to the medical community’s growth.

💡 Legacy and Future Contributions

With a passion for advancing pediatric neurology, Dr. Kollia continues to shape the future of medical research and patient care. Her work in understanding movement disorders in children with epileptic encephalopathy holds the potential to improve diagnostic and therapeutic approaches in pediatric neurology. As she progresses in her career, her contributions to both clinical practice and scientific research will undoubtedly leave a lasting impact on the medical community and the lives of the children she treats.

 

Publication

  • Title: The genetic etiology in cerebral palsy mimics: the results from a Greek tertiary care center
    Authors: V Zouvelou, D Yubero, L Apostolakopoulou, E Kokkinou, M Bilanakis, …
    Year: 2019

 

  • Title: MOTOR PHENOTYPING IN A GREEK COHORT OF PATIENTS WITH NEONATAL AND INFANTILE ONSET DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
    Authors: E Kollia, E Kokkinou, C Outsika, G Koltsida, V Zouvelou, A Vontzalidis, …
    Year: 2025

 

🌟 Conclusion

Ms. Kollia’s journey exemplifies the perfect blend of academic excellence, professional expertise, and compassionate patient care. Through her research and clinical endeavors, she continues to advance the understanding and treatment of pediatric neurological disorders. Her unwavering dedication to improving children’s health positions her as a leading figure in pediatric medicine. With her vision for excellence and continued contributions, she is set to leave a lasting impact on the medical field, inspiring future generations of healthcare professionals.